Article
Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.
Virology journal - 9 Apr 2015
Kwon Oh-Kyung, Kim Sung Soon, Rhee Jee Eun, Kee Mee-Kyung, Park Mina, Oh Hye-Ri, Choi Ju-Yeon
Abstract excerpt
BACKGROUND: In South Korea, about 20 types of antiretroviral drugs are used in the treatment of patients with human immunodeficiency virus/acquired immune deficiency syndrome. Since 2010, raltegravir, etravirine, and darunavir have been spotlighted as new drugs for highly active antiretroviral therapy (HAART)-experienced adults with resistant HIV-1 in South Korea. In this study, we investigated potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
